Form 4 Filing for Elanco Animal Health Inc - Officer Transaction

Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., reported a transaction on April 17, 2026. The filing indicates the acquisition of 119.3805 Deferred Stock Units (DSUs) with a price per unit of $23.68. These DSUs, which represent the right to receive one share of Company common stock or its cash equivalent, will settle in cash or shares following termination of employment or during a specified future year. Post-transaction, Mr. Simmons holds 24038.5303 DSUs. The reporting owner is Simmon Jeffrey N, with a cik of 0001479079. The issuer is Elanco Animal Health Inc, with a cik of 0001739104 and trading symbol ELAN. The filing is a Form 4 document.